Affiliation:
1. U.S. Food and Drug Administration, Center for Food Safety Applied Nutrition, College Park, Maryland 20740
2. Centers for Disease Control and Prevention, Atlanta, Georgia
Abstract
ABSTRACT
An amplified enzyme-linked immunosorbent assay (ELISA) for the detection of
Clostridium botulinum
complex neurotoxins was evaluated for its ability to detect these toxins in food. The assay was found to be suitable for detecting type A, B, E, and F botulinum neurotoxins in a variety of food matrices representing liquids, solid, and semisolid food. Specific foods included broccoli, orange juice, bottled water, cola soft drinks, vanilla extract, oregano, potato salad, apple juice, meat products, and dairy foods. The detection sensitivity of the test for these botulinum complex serotypes was found to be 60 pg/ml (1.9 50% lethal dose [LD
50
]) for botulinum neurotoxin type A (BoNT/A), 176 pg/ml (1.58 LD
50
) for BoNT/B, 163 pg/ml for BoNT/E (4.5 LD
50
), and 117 pg/ml for BoNT/F (less than 1 LD
50
) in casein buffer. The test could also readily detect 2 ng/ml of neurotoxins type A, B, E, and F in a variety of food samples. For specificity studies, the assay was also used to test a large panel of type A
C. botulinum
, a smaller panel of proteolytic and nonproteolytic type B, E, and F neurotoxin-producing
Clostridia
, and nontoxigenic organisms using an overnight incubation of toxin production medium. The assay appears to be an effective tool for large-scale screening of the food supply in the event of a botulinum neurotoxin contamination event.
Publisher
American Society for Microbiology
Subject
Ecology,Applied Microbiology and Biotechnology,Food Science,Biotechnology
Reference49 articles.
1. Andreadis, J. D., J. J. Kools, J. K. Dykes, and J. L. Ferreira, and S. E. Maslanka. 2003. Development of an in vitro DIG-ELISA assay for detection of Clostridium botulinum neurotoxin serotype A, B, E and F, abstr. 56. In Future directions for biodefense research: development of countermeasures. Proceedings of the ASM Biodefense Research Meeting. American Society for Microbiology, Washington, D.C.
2. Arnon, S. S., R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, J. Hauer, M. Layton, S. Lillibridge, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, D. L. Swerdlow, and K. Tonat. 2001. Botulinum toxin as a biological weapon: medical and public health management. JAMA285:1059-1070.
3. Binz, T., H. Kurazono, M. Wille, J. Frevert, K. Wernars, and H. Niemann. 1990. The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J. Biol. Chem.265:9153-9158.
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. Burkard, F., F. Chen, G. M. Kuziemko, and R. C. Stevens. 1997. Electron density projection map of the botulinum neurotoxin 900-kilodalton complex by electron crystallography. J. Struct. Biol.120:78-84.
Cited by
128 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献